Colinz Laboratories Limited (BOM:531210)
India · Delayed Price · Currency is INR 51.74
-2.72 (-4.99%)
At close: Feb 12, 2026
Colinz Laboratories Market Cap
Colinz Laboratories has a market cap or net worth of 126.66 million as of February 13, 2026. Its market cap has decreased by -8.58% in one year.
Market Cap
126.66M
Enterprise Value
59.06M
Revenue
58.40M
Ranking
n/a
PE Ratio
25.65
Stock Price
51.74
Market Cap Chart
Since May 26, 2005, Colinz Laboratories's market cap has increased from 39.08M to 126.66M, an increase of 224.09%. That is a compound annual growth rate of 5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 126.66M | -6.25% |
| Dec 31, 2025 | 135.10M | -23.12% |
| Dec 31, 2024 | 175.73M | 74.40% |
| Dec 29, 2023 | 100.76M | -48.73% |
| Dec 30, 2022 | 196.55M | 55.52% |
| Dec 31, 2021 | 126.39M | 93.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 161.38M |
| Sunrest Lifescience | 157.92M |
| Hamps Bio | 149.85M |
| Norris Medicines | 142.51M |
| Emmessar Biotech & Nutrition | 138.89M |
| Rekvina Laboratories | 129.36M |
| Cian Healthcare | 125.23M |
| Beryl Drugs | 110.97M |